All lobbying filings

NATIONAL MARROW DONOR PROGRAM

Lobbying for NATIONAL MARROW DONOR PROGRAM

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate · $320,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 12

S 1227
ABC Act
HR 2491
ABC Act
HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
S 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2026
S 752
Accelerating Kids’ Access to Care Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 925
Credit for Caring Act of 2025
HR 2036
Credit for Caring Act of 2025
HR 5178
Sickle Cell Disease Comprehensive Care Act
S 721
Sickle Cell Disease Comprehensive Care Act
S 1565
Lowering Costs for Caregivers Act of 2025
HR 138
Lowering Costs for Caregivers Act of 2025

Lobbying activity 3

Health Issues

Alleviating Barriers for Caregivers (House and Senate), S. 1227/H.R. 2491. Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Accelerating Kids Access to Care Act (House and Senate), S. 752/H.R. 1509. Credit for Caring Act (House and Senate), S. 925/H.R. 2036. Sickle Cell Disease Comprehensive Care Act (House and Senate), H.R. 5178/S. 721. Lowering Costs for Caregives Act (House and Senate), S. 1565/H.R. 138.

Budget/Appropriations

Continued funding for the C.W. Bill Young Cell Transplantation Program. Increased funding to expand patient access to transplants. Increased medical research funding.

Transportation

Donated bone marrow/cell transportation for life-saving transplant.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.